Navigation Links
AMN Healthcare Reports Second Quarter 2008 Results

SAN DIEGO, Aug. 6 /PRNewswire-FirstCall/ -- AMN Healthcare Services, Inc. (NYSE: AHS), the nation's largest healthcare staffing company and the market leader in all of its business segments today reported revenue of $313 million, a 6% increase from the same quarter last year and a 7% increase from last quarter. Additional highlights include:

-- All three business segments: Nurse & Allied, Locum Tenens and Physician Permanent Placement, experienced organic sequential revenue growth in the second quarter of 2008.

-- Gross margin for the quarter was 26.4%, up 90 basis points from the same quarter last year.

-- Net income for the quarter was $9.4 million, or $0.27 per share, a 4% increase over the $0.26 per share in the same quarter last year and within the Company's previously-announced guidance range of $0.26 to $0.28 per share.

Susan R. Nowakowski, President and Chief Executive Officer of AMN Healthcare, remarked, "All of our business lines experienced volume and revenue growth during the second quarter, reflecting the solid fundamentals of our industry and execution by our team. This success is further magnified by our ability to improve gross margins and gain modest pricing improvements, despite relatively flat hospital admissions and an overall soft economic environment. AMN's strategy to offer a diverse product line across a broad client base and our leadership position in the fastest-growing, most profitable segments of the healthcare staffing industry is proving its value to our shareholders."

For the second quarter of 2008, revenue for the Nurse and Allied healthcare staffing segment was $215.3 million, an increase of 7% from the same quarter last year. The Locum Tenens staffing segment generated re 8.7%

As of June 30,

2008 2007


Ratio(5) 1.6 1.8

(1) Adjusted EBITDA represents net income plus interest expense (net of

interest income), income taxes, depreciation and amortization and

stock-based compensation expense. Management presents adjusted EBITDA

because it believes that adjusted EBITDA is a useful supplement to net

income as an indicator of operating performance. Management believes

that adjusted EBITDA is an industry-wide financial measure that is

useful both to management and investors when evaluating the Company's

performance. Management also uses adjusted EBITDA for planning

purposes. Management uses adjusted EBITDA to evaluate the Company's

performance because it believes that adjusted EBITDA more accurately

reflects the Company's results, as it excludes certain items, in

particular stock-based compensation charges that management believes

are not indicative of the Company's operating performance. However,

adjusted EBITDA is not intended to represent cash flows for the

period, nor has it been presented as an alternative to operating or

net income as an indicator of operating performance, and it should not

be considered in isolation or as a substitute for measures of

performance prepared in accordance with GAAP. As defined, adjusted

EBITDA is not necessarily comparable to other similarly titled

captions of other companies due to potential inconsistencies in the

method of calculation. While management believes that some of the

items excluded from adjusted EBITDA are not indicative of the

Company's operating performance, these items do impact the income

statement, and management therefore utilizes adjusted EBITDA as an

operating performance measure in conjunction with GAAP measures such

as net income.

(2) Average travelers on assignment represents the average number of nurse

and allied healthcare professionals on assignment during the period


(3) Revenue per traveler per day and gross profit per traveler per day

represent the revenue and gross profit of the Company's nurse and

allied healthcare staffing segment divided by average travelers on

assignment, divided by the number of days in the period presented.

(4) Days filled is calculated by dividing the locum tenens hours filled

during the period by 8 hours. Revenue per day filled and gross profit

per day filled represent revenue and gross profit of the Company's

locum tenens staffing segment divided by days filled for the period


(5) Leverage ratio represents the ratio of the total debt outstanding at

the end of the period to the Adjusted EBITDA for the past twelve


AMN Healthcare Services, Inc.

Condensed Consolidated Balance Sheets

(in thousands)


June 30, March 31, December 31,

2008 2008 2007


Current assets:

Cash and cash equivalents $8,356 $7,835 $18,495

Accounts receivable, net 198,201 199,091 184,741

Income taxes receivable 1,049 -- --

Deferred income taxes, net 28,081 28,081 28,084

Other current assets 15,584 14,938 11,631

Total current assets 251,271 249,945 242,951

Fixed assets, net 25,326 25,246 24,600

Goodwill, net 252,823 252,823 241,266

Intangible assets, net 125,254 126,418 113,535

Other assets 12,048 11,198 11,274

Total assets $666,722 $665,630 $633,626

Liabilities and

stockholders' equity

Current liabilities:

Bank overdraft $2,786 $6,617 $--

Accounts payable and

accrued expenses 28,987 28,624 22,231

Accrued compensation and

benefits 48,855 47,328 43,446

Income taxes payable -- 3,159 2,925

Revolving credit facility 24,500 13,500 --

Current portion of notes

payable 15,427 15,339 26,616

Deferred revenue 8,006 8,322 7,647

Other current liabilities 17,109 25,652 25,691

Total current liabilities 145,670 148,541 128,556

Notes payable, less current

portion 113,771 117,628 120,352

Deferred income taxes, net 69,706 70,637 71,092

Other long-term liabilities 41,201 41,806 37,498

Total liabilities 370,348 378,612 357,498

Stockholders' equity 296,374 287,018 276,128

Total liabilities and

stockholders' equity $666,722 $665,630 $633,626

AMN Healthcare Services, Inc.

Condensed Consolidated Cash Flow Statement

(in thousands)


Three Months Ended Six Months Ended

June 30, June 30, June 30, June 30,

2008 2007 2008 2007

Net cash provided by

operating activities $11,883 $16,251 $28,756 $33,493

Net cash used in

investing activities (11,064) (7,983) (44,465) (10,114)

Net cash provided by

(used in) financing

activities (345) (984) 5,589 (10,288)

Effect of exchange

rates on cash 47 22 (19) 14

Net increase

(decrease) in cash

and cash equivalents 521 7,306 (10,139) 13,105

Cash and cash

equivalents at

beginning of period 7,835 10,221 18,495 4,422

Cash and cash

equivalents at end

of period $8,356 $17,527 $8,356 $17,527

venue of $83.9 million, an increase of 5% from the same quarter last year and the Physician Permanent Placement segment provided revenue of $13.5 million, an increase of 7% from the same quarter last year.

Gross profit for the second quarter of 2008 was $82.5 million, an increase of 10% from the same quarter last year. Gross margin this quarter increased 90 basis points to 26.4% from 25.5% in the same quarter last year reflecting mainly an improved pay-to-bill spread in our nurse and allied staffing segment. Housing costs, which had been trending higher for several quarters, remained flat in the second quarter as a percentage of revenue compared to the same quarter last year.

Selling, general and administrative ("SG&A") expenses increased to 19.2% of revenue in the second quarter of 2008 from 18.2% in the same quarter last year. The increase was due mostly to higher insurance costs and bad debt expense associated with a client bankruptcy in our locum tenens staffing business as well as expenses in support of strategic initiatives to further diversify and augment our future growth. Despite the increase in SG&A this quarter, diluted earnings per share grew 4% to $0.27 compared to the same quarter last year due to the higher revenue and improvement in gross margin.

Revenue and Earnings Guidance for Third Quarter and Full Year 2008

Based on trends experienced in the first month of the third quarter and taking into account expected seasonal patterns for the third and fourth quarters, the Company reaffirmed its projected earnings per share growth of 11% to 16% over 2007 and revised its projected revenue growth for the full year 2008 to 6% to 8%. For the third quarter of 2008, the Company expects revenue to range from $320 million to $323 million and diluted earnings per share to range from $0.31 to $0.33.

Nowakowski added, "We expect all of our business segments to continue to drive both year-over-year and sequential quarterly revenue growth in the third quarter. Just as important, we also expect gross margins to remain relatively stable and, with continued improvements in operational efficiency, we expect to grow earnings at a stronger pace than revenue."

Stock Repurchase Program Update

The Company is authorized to purchase up to $38 million of its outstanding common stock in the open market through March 31, 2009. The Company initiated the share buyback during the second quarter of 2008 and purchased 368,000 shares of its common stock for approximately $6.4 million, or $17.49 per share. Diluted shares outstanding at June 30, 2008 were approximately 34.3 million.

Company Summary

AMN Healthcare Services, Inc. is the largest healthcare staffing company in the United States and the largest nationwide provider in all four of its business lines: travel nurse staffing, locum tenens staffing (temporary physician staffing), physician permanent placement services and travel allied staffing. AMN Healthcare recruits healthcare professionals both nationally and internationally and places them on variable lengths of assignments and in permanent positions at acute-care hospitals, physician practice groups and other healthcare settings throughout the United States. For more information, visit

Conference Call on August 6, 2008

AMN Healthcare Services, Inc.'s second quarter 2008 conference call will be held on Wednesday, August 6, 2008, at 5:00 p.m., Eastern Time. A live webcast of the call can be accessed through AMN Healthcare's website at Please log in at least 10 minutes prior to the conference call in order to download the applicable audio software. Interested parties may participate live via telephone by dialing (888) 428-4480 in the U.S. or (651) 291-5254 internationally. Following the conclusion of the call, a replay of the webcast will be available at the Company's website. Alternatively, a telephonic replay of the call will be available at 7:30 p.m. Eastern Time on August 6, 2008, and can be accessed until August 20, 2008 at midnight Eastern Time, by calling (800) 475-6701 in the U.S. or (320) 365-3844 internationally, with access code 931165.

This earnings release contains certain non-GAAP financial information. These measures are not in accordance with, or an alternative to, generally accepted accounting principles in the United States ("GAAP"), and may be different from non-GAAP measures reported by other companies. From time to time, additional information regarding non-GAAP financial measures may be made available on the Company's website at

Forward-Looking Statements

This earnings release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include the revenue and earnings guidance for the third quarter and full year of 2008, and Ms. Nowakowski's comments, including those regarding future growth in revenue and earnings. The Company based these forward-looking statements on its current expectations and projections about future events. Actual results could differ materially from those discussed in, or implied by, these forward-looking statements. Forward-looking statements are identified by words such as "believe," "anticipate," "expect," "intend," "plan," "will," "may" and other similar expressions. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements. The following factors could cause the Company's actual results to differ materially from those implied by the forward-looking statements in this earnings release: the Company's ability to continue to recruit qualified temporary and permanent healthcare professionals at reasonable costs; the Company's ability to retain qualified temporary healthcare professionals for multiple assignments at reasonable costs; the Company's ability to attract and retain sales and operational personnel; the Company's ability to enter into contracts with hospitals, healthcare facility clients, affiliated healthcare networks and physician practice groups on terms attractive to the Company and to secure orders related to those contracts; the Company's ability to demonstrate the value of its services to its healthcare and facility clients; the Company's ability to maintain and enhance the brand identities it has developed, at reasonable costs; changes in the timing of hospital, healthcare facility and physician practice group clients' orders for temporary healthcare professionals; the general level of patient occupancy and utilization of services at hospital and healthcare facility clients' facilities, including the potential impact on such utilization caused by adoption of alternative modes of healthcare delivery, which utilization may influence demand for the Company's services; the overall level of demand for services offered by temporary and permanent healthcare staffing providers; the ability of hospital, healthcare facility and physician practice group clients to retain and increase the productivity of their permanent staff; the variation in pricing of the healthcare facility contracts under which the Company places temporary healthcare professionals; the Company's ability to successfully design its strategic growth, acquisition and integration strategies and to implement those strategies, including integration of acquired companies' accounting, management information, human resource and other administrative systems, and implementation or remediation of controls, procedures and policies at acquired companies; the Company's ability to leverage its cost structure; access to and undisrupted performance of the Company's management information and communication systems, including use of the Internet, and candidate and client databases and payroll and billing software systems; the Company's ability to keep its web sites operational at a reasonable cost and without service interruptions; the effect of existing or future government legislation and regulation; the Company's ability to grow and operate its business in compliance with legislation and regulations, including regulations that may affect the Company's clients and, in turn, affect demand for the Company's services; the challenge to the classification of certain of the Company's healthcare professionals as independent contractors; the impact of medical malpractice and other claims asserted against the Company; the disruption or adverse impact to the Company's business as a result of a terrorist attack or breach of security of our data systems; the Company's ability to carry out its business strategy and maintain sufficient cash flow and capital structure to support its business; the loss of key officers and management personnel that could adversely affect the Company's ability to remain competitive; the effect of recognition by the Company of an impairment to goodwill; and the effect of adjustments by the Company to accruals for self-insured retentions. Other factors that could cause actual results to differ from those implied by the forward-looking statements contained in this earnings release are set forth in the Company's Annual Report on Form 10-K for the year ended December 31, 2007, and its Current Reports on Form 8-K. These statements reflect the Company's current beliefs and are based upon information currently available to it. Be advised that developments subsequent to this earnings release are likely to cause these statements to become outdated with the passage of time. The Company does not intend, however, to update the guidance provided today prior to its next earnings release.



David C. Dreyer

Chief Financial Officer

Christopher Schwartz

Vice President, Financial Reporting and Investor Relations


AMN Healthcare Services, Inc.

Condensed Consolidated Statements of Income

(dollars in thousands, except per share amounts)


Three Months Ended Six Months Ended

June 30, June 30,

2008 2007 % Chg 2008 2007 % Chg

Revenue $312,691 $293,912 6.4% $606,284 $577,856 4.9%

Cost of revenue 230,153 218,953 5.1% 446,291 430,392 3.7%

Gross profit 82,538 74,959 10.1% 159,993 147,464 8.5%

26.4% 25.5% 26.4% 25.5%




general and

administrative 60,117 53,520 12.3% 115,220 106,571 8.1%

19.2% 18.2% 19.0% 18.4%



amortization 3,738 2,857 30.8% 7,088 5,486 29.2%



expenses 63,855 56,377 13.3% 122,308 112,057 9.1%

Income from

operations 18,683 18,582 0.5% 37,685 35,407 6.4%

6.0% 6.3% 6.2% 6.1%

Interest expense,

net 2,660 3,124 -14.9% 5,471 6,458 -15.3%

Income before

income taxes 16,023 15,458 3.7% 32,214 28,949 11.3%

Income tax

expense 6,656 6,212 7.1% 13,331 11,509 15.8%

Net income $9,367 $9,246 1.3% $18,883 $17,440 8.3%

3.0% 3.1% 3.1% 3.0%

Net income per

common share:

Basic $0.28 $0.27 3.7% $0.56 $0.50 12.0%

Diluted $0.27 $0.26 3.8% $0.55 $0.49 12.2%

Weighted average

common shares


Basic 33,833 34,723 -2.6% 33,832 34,681 -2.4%

Diluted 34,308 35,273 -2.7% 34,244 35,278 -2.9%

AMN Healthcare Services, Inc.

Supplemental Financial and Operating Data

(dollars in thousands, except operating data)


Three Months Ended Six Months Ended

June 30, June 30,

% of % of % of % of

2008 Rev 2007 Rev 2008 Rev 2007 Rev


Nurse and



staffing $215,342 $201,322 $419,327 $401,297

Locum tenens

staffing 83,857 79,937 160,210 151,342




services 13,492 12,653 26,747 25,217

$312,691 $293,912 $606,284 $577,856



Nurse and



staffing $16,692 7.8% $13,635 6.8% $32,173 7.7% $27,366 6.8%

Locum tenens

staffing 4,247 5.1% 7,040 8.8% 9,902 6.2% 11,058 7.3%




services 3,864 28.6% 2,923 23.1% 7,203 26.9% 6,423 25.5%

24,803 7.9% 23,598 8.0% 49,278 8.1% 44,847 7.8%



amortization 3,738 2,857 7,088 5,486


compensation 2,382 2,159 4,505 3,954


expense, net 2,660 3,124 5,471 6,458

Income before

income taxes 16,023 15,458 32,214 28,949

Income tax

expense 6,656 6,212 13,331 11,509

Net income $9,367 $9,246 $18,883 $17,440

Three Months Ended Six Months Ended

June 30, June 30,

2008 2007 % Chg 2008 2007 % Chg

Gross Margin

Nurse and



staffing 24.5% 23.3% 24.3% 23.3%

Locum tenens

staffing 25.8% 25.6% 26.3% 25.4%




services 59.7% 60.0% 60.6% 61.6%

Operating Data:

Nurse and





travelers on

assignment(2) 7,207 7,017 2.7% 7,047 7,024 0.3%

Revenue per


per day(3) $328.35 $315.28 4.1% $326.95 $315.65 3.6%

Gross profit

per traveler

per day(3) $80.52 $73.49 9.6% $79.30 $73.52 7.9%

Locum tenens



filled(4) 57,859 57,602 0.4% 110,558 109,901 0.6%

Revenue per


filled(4) $1,449.33 $1,387.75 4.4% $1,449.10 $1,377.08 5.2%

Gross profit

per day

filled(4) $374.62 $355.01 5.5% $380.50 $350.02

SOURCE AMN Healthcare Services, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
2. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
3. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
4. Dr. Paul Bandt Celebrates 35th Anniversary With Desert Radiologists and a History of Healthcare in Las Vegas
5. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
6. MDS to Present at Thomas Weisel Partners Healthcare Conference
7. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
8. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
9. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
10. Kingfisher Healthcare (KFH) Achieves World Class Quality Platform
11. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
Post Your Comments:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned by ... to enhance the health of felines. The formula is all-natural and is made from ... the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Research and Markets has announced the addition ... - Forecast to 2022" report to their offering. ... to date financial data derived from varied research sources to ... potential impact on the market during the next five years, ... of sub markets, regional and country level analysis. The report ...
(Date:6/23/2016)... , June 23, 2016 Bracket , ... launch its next generation clinical outcomes platform, Bracket eCOA (SM) ... held on June 26 – 30, 2016 in ... first electronic Clinical Outcome Assessment product of its kind to ... #715. Bracket eCOA 6.0 is a flexible platform ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas ... Brasil as the company,s second affiliate in Latin America . ... ... of Astellas Farma Colombia ... ...
Breaking Medicine Technology: